KR0177510B1 - 에스케리키아 콜리 백신 - Google Patents

에스케리키아 콜리 백신 Download PDF

Info

Publication number
KR0177510B1
KR0177510B1 KR1019900012764A KR900012764A KR0177510B1 KR 0177510 B1 KR0177510 B1 KR 0177510B1 KR 1019900012764 A KR1019900012764 A KR 1019900012764A KR 900012764 A KR900012764 A KR 900012764A KR 0177510 B1 KR0177510 B1 KR 0177510B1
Authority
KR
South Korea
Prior art keywords
escherichia coli
toxin
flagella
vaccine
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019900012764A
Other languages
English (en)
Korean (ko)
Other versions
KR910004209A (ko
Inventor
프란시스커스 반덴 보쉬 요하네스
Original Assignee
에프. 지. 엠. 헤르만스; 피.씨. 샬크비크
악조 엔. 브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에프. 지. 엠. 헤르만스; 피.씨. 샬크비크, 악조 엔. 브이. filed Critical 에프. 지. 엠. 헤르만스; 피.씨. 샬크비크
Publication of KR910004209A publication Critical patent/KR910004209A/ko
Application granted granted Critical
Publication of KR0177510B1 publication Critical patent/KR0177510B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1019900012764A 1989-08-18 1990-08-17 에스케리키아 콜리 백신 Expired - Fee Related KR0177510B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP89.202110.6 1989-08-18
EP892021106 1989-08-18
EP89202110 1989-08-18

Publications (2)

Publication Number Publication Date
KR910004209A KR910004209A (ko) 1991-03-28
KR0177510B1 true KR0177510B1 (ko) 1999-03-20

Family

ID=8202455

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900012764A Expired - Fee Related KR0177510B1 (ko) 1989-08-18 1990-08-17 에스케리키아 콜리 백신

Country Status (16)

Country Link
US (1) US5750115A (cg-RX-API-DMAC7.html)
EP (1) EP0413378B1 (cg-RX-API-DMAC7.html)
JP (1) JP3031561B2 (cg-RX-API-DMAC7.html)
KR (1) KR0177510B1 (cg-RX-API-DMAC7.html)
CN (1) CN1062605C (cg-RX-API-DMAC7.html)
AU (1) AU635062B2 (cg-RX-API-DMAC7.html)
CA (1) CA2022420C (cg-RX-API-DMAC7.html)
DE (1) DE69016129T2 (cg-RX-API-DMAC7.html)
DK (1) DK0413378T3 (cg-RX-API-DMAC7.html)
ES (1) ES2070266T3 (cg-RX-API-DMAC7.html)
GR (1) GR3015782T3 (cg-RX-API-DMAC7.html)
HU (2) HU210965B (cg-RX-API-DMAC7.html)
IL (1) IL95175A (cg-RX-API-DMAC7.html)
NZ (1) NZ234933A (cg-RX-API-DMAC7.html)
TW (1) TW204353B (cg-RX-API-DMAC7.html)
ZA (1) ZA906100B (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042718T3 (es) * 1987-10-26 1993-12-16 Akzo Nv Procedimiento para la preparacion de una vacuna para proteger aves de corral contra septicemia producida por e. coli.
US6749831B1 (en) * 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
JP2001527562A (ja) * 1997-05-16 2001-12-25 メディカル ディフェンス テクノロジーズ エルエルシー リポ多糖コアに対するワクチン
WO1999059626A1 (en) * 1998-05-15 1999-11-25 Mkb Investments Limited Partnership Compositions and method for immunizing poultry
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
EP1934349A4 (en) * 2005-08-30 2009-05-27 Commw Scient Ind Res Org BACTERIAL INTRODUCTION OF BIOLOGICALLY ACTIVE POLYPEPTIDES
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
CN102905522A (zh) 2009-10-12 2013-01-30 新健康科学股份有限公司 用于从红细胞中除去氧的氧消耗装置和方法
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
BR112012008683B8 (pt) 2009-10-12 2022-11-08 Hemanext Inc dispositivo de armazenagem de sangue para armazenar sangue depletado de oxigênio e dióxido de carbono, dispositivo de depleção de oxigênio e dióxido de carbono, método para remover oxigênio e dióxido de carbono de hemácias, sistema de armazenagem de sangue, dispositivo de armazenagem de sangue, método para remover oxigênio de hemácias e método para aumentar os níveis de adenosina trifosfato (atp) nas hemácias
WO2012027582A1 (en) 2010-08-25 2012-03-01 New Health Sciences Method for enhancing red blood cell quality and survival during storage
EP4218412A1 (en) 2010-11-05 2023-08-02 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
US8926980B2 (en) * 2011-07-11 2015-01-06 Camas Incorporated Compositions against bacterial toxins
AU2012294269B2 (en) 2011-08-10 2016-11-24 Hemanext Inc. Integrated leukocyte, oxygen and/or CO2 depletion, and plasma separation filter device
CA2902061C (en) 2013-02-28 2023-08-08 New Health Sciences, Inc. Gas depletion and gas addition devices for blood treatment
KR20250033333A (ko) 2015-03-10 2025-03-07 헤마넥스트 인코포레이티드 산소 감소 1회용 키트, 장치 및 이의 사용 방법
BR122022005103B1 (pt) 2015-04-23 2023-03-14 Hemanext Inc Dispositivo de armazenamento de sangue para armazenar sangue depletado de oxigênio e método para armazenar sangue depletado de oxigênio
PT3297641T (pt) 2015-05-18 2025-10-09 Hemanext Inc Métodos de armazenamento de sangue total e respetivas composições
CN109195632A (zh) 2016-05-27 2019-01-11 新健康科学股份有限公司 厌氧血液储存和病原体失活方法
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
US12138302B2 (en) 2020-10-27 2024-11-12 Pfizer Inc. Escherichia coli compositions and methods thereof
US12357681B2 (en) 2020-12-23 2025-07-15 Pfizer Inc. E. coli FimH mutants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135819A (ja) * 1982-02-09 1983-08-12 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4702911A (en) 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
ES2060580T3 (es) * 1986-03-11 1994-12-01 Shionogi & Co Adn que tiene una secuencia adn codificante de la proteina flagelina y vector que la contiene.

Also Published As

Publication number Publication date
CA2022420C (en) 2000-03-28
TW204353B (cg-RX-API-DMAC7.html) 1993-04-21
GR3015782T3 (en) 1995-07-31
AU635062B2 (en) 1993-03-11
HU210965B (en) 1995-09-28
JPH03184996A (ja) 1991-08-12
HU905053D0 (en) 1991-01-28
DE69016129D1 (de) 1995-03-02
AU6109990A (en) 1991-02-21
US5750115A (en) 1998-05-12
JP3031561B2 (ja) 2000-04-10
ZA906100B (en) 1991-05-29
NZ234933A (en) 1992-06-25
EP0413378B1 (en) 1995-01-18
IL95175A (en) 1994-05-30
CN1049523A (zh) 1991-02-27
HUT59612A (en) 1992-06-29
EP0413378A1 (en) 1991-02-20
HU211827A9 (en) 1995-12-28
DK0413378T3 (da) 1995-05-15
DE69016129T2 (de) 1995-05-24
CN1062605C (zh) 2001-02-28
IL95175A0 (en) 1991-06-10
KR910004209A (ko) 1991-03-28
CA2022420A1 (en) 1991-02-19
ES2070266T3 (es) 1995-06-01

Similar Documents

Publication Publication Date Title
JP3031561B2 (ja) 大腸菌ワクチン
Andrews et al. Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge
KR100361562B1 (ko) 프로테이나제k에대해내성을갖는네이쎄리아메닝기티디스의표면단백질
Ezzell Jr et al. Immunological analysis of cell-associated antigens of Bacillus anthracis
CA2040544C (en) Actinobacillus pleuropneumoniae subunit vaccine
Ortiz et al. Immunoblot detection of class-specific humoral immune response to outer membrane proteins isolated from Salmonella typhi in humans with typhoid fever
Fiske et al. Method for reducing endotoxin in Moraxella catarrhalis UspA2 protein preparations
US11633466B2 (en) Enteric fever vaccine based on outer membrane vesicles from two different strains of typhoidal Salmonelle species
Arciniega et al. Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis
DK173361B1 (da) Isoleret proteinholdigt materiale, dræbte hele celler af Pasteurella hæmolytica, vaccine mod Pasteurella og fremgangsmåde t
US5593679A (en) Poultry vaccine against E. coli air sac inflammation and septicaemia
WO2004041182A2 (en) M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever
AU740048B2 (en) Compositions and methods for administering borrelia burgdorferi antigens
Gogolewski et al. Immunodominant antigens of zoospores from ovine isolates of Dermatophilus congolensis
RU2683027C2 (ru) Поливалентная иммунизирующая и/или терапевтическая композиция для применения при бактериальных инфекциях или пищевом отравлении, в частности сальмонеллёзе, способ получения этой композиции, её применение и вакцина, содержащая эту композицию
Rathore et al. Protein Profile of Sonicated Salmonella Gallinarum Antigen Employing Homologous and Heterologous Anti-Sera of Reference and Field Strain
WO1998032769A1 (en) Antigen
Woods et al. Purification and serological characterization of a type-specific antigen of Streptococcus equisimilis
KR20020032772A (ko) 살모넬라균에 대한 난황항체
WO2008004902A2 (en) Protein, their fragment and use thereof
Mahasreshti OmpA family protein of Pasteurella haemolytica: purification, partial characterization and potential immunologic significance
Ayalew et al. Characterization of Immunodominant and

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R14-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 13

FPAY Annual fee payment

Payment date: 20111107

Year of fee payment: 14

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 14

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20121119

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20121119